Coscia Lisa A, Constantinescu Serban, Moritz Michael J, Radomski John S, Gaughan William J, McGrory Carolyn H, Armenti Vincent T
Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
Clin Transpl. 2007:29-42.
From the first reports of pregnancy in each of the organ groups to the present, concerns varied and were specific to the type of transplant. Organ-specific issues still require additional attention and analyses. Lung recipients appear at greatest risk for poorer pregnancy outcomes. Given these ongoing concerns and the constant advent of new developments, clinicians are responsible for providing pregnancy counseling in all pre- and posttransplant recipients of childbearing age. As individual physicians and centers accrue experience with these major therapeutic decisions, it is critical that both positive and negative outcomes be reported in appropriate settings-symposia, meetings, publications, and registries. Future analyses from the NTPR are directed at potential effects of newer immunosuppressive regimens, not only from immediate exposure, but also from continued exposures such as may occur from breastfeeding. As the registry study design allows for contact between registry staff and recipients and their health care providers, efforts are ongoing to analyze long-term outcomes of parent and child. Continued close collaboration among specialists will help to identify potential pregnancy risks in these populations, particularly as new immunosuppressive agents are developed. Therefore, centers are encouraged to report all pregnancy exposures in transplant recipients to the NTPR. The 50th anniversary of the first posttransplant pregnancy (reported by Joseph Murray, et al. (11)) was in March 2008. With this important landmark event and with ongoing pregnancy issues concerning posttransplant pregnancy safety, this is an ideal time to raise the awareness of the need for continued worldwide cooperation for data collection. Enhanced assessment of pregnancy safety is essential to the development of guidelines for counseling and management of pregnancy in the transplant population.
从各器官组首次报告妊娠情况至今,相关问题各不相同,且因移植类型而异。特定器官的问题仍需更多关注和分析。肺移植受者出现不良妊娠结局的风险似乎最大。鉴于这些持续存在的问题以及新进展不断涌现,临床医生有责任为所有育龄期移植前后的受者提供妊娠咨询。随着个体医生和中心在这些重大治疗决策方面积累经验,在适当场合——研讨会、会议、出版物和登记处报告正反两方面的结果至关重要。国家移植妊娠登记处(NTPR)未来的分析将针对新型免疫抑制方案的潜在影响,不仅包括直接接触的影响,还包括母乳喂养等持续接触可能产生的影响。由于登记研究设计允许登记处工作人员与受者及其医疗服务提供者取得联系,目前正在努力分析父母和孩子的长期结局。专家之间持续密切合作将有助于识别这些人群中的潜在妊娠风险,尤其是在开发新的免疫抑制剂时。因此,鼓励各中心向NTPR报告移植受者的所有妊娠暴露情况。2008年3月是首次移植后妊娠(由约瑟夫·默里等人报道)50周年。鉴于这一重要的标志性事件以及移植后妊娠安全性方面持续存在的妊娠问题,这是一个提高对全球持续合作收集数据必要性认识的理想时机。加强对妊娠安全性的评估对于制定移植人群妊娠咨询和管理指南至关重要。